Cyclerion Therapeutics Inc (CYCN) stock forecast · $8.6M cap
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
This CYCN forecast page states what the cached financials imply — not a price target and not a guarantee. Cyclerion Therapeutics Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
Period-over-period revenue change is not in cache for CYCN, so this page does not invent a growth rate.
CYCN currently screens at market cap $8.6M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next CYCN 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the CYCN stock page.
Not investment advice.